Riskpilot← Back to searchSign inGet full accessInorelax AB
ABActiveOrg 5568808074Rindögatan 14 Lgh 0901Site preparation · NACE 4312Est. 20120 employees
Revenue 2024
SEK 962K
-18% vs 2023
EBITDA margin
39.7%
-50% vs 2023
Equity ratio
99.3%
Financial strength
Net profit 2024
SEK 18,1M
+6158% vs 2023
| Revenue | SEK 962K | -18% |
| EBITDA | SEK 382K | -50% |
| Net profit | SEK 18,1M | +6158% |
| Total assets | SEK 30M | +132% |
| Equity | SEK 29,7M | +135% |
| Employees | 0 | — |
Legal name
Inorelax AB
Org number
5568808074
Legal form
Aktiebolag
NACE code
4312 · Site preparation
Founded
14 januari 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva innehav samt förvaltning av värdepapper och därmed förenlig verksamhet.
Address
Rindögatan 14 Lgh 0901
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 77 | 819 | 1 178 | 962 |
| Staff expenses | — | −23 | −0 | — | — |
| EBITDA | −62 | −1 372 | −556 | 767 | 382 |
| Depreciation & amort. | −0 | — | −475 | −475 | −508 |
| EBIT | −62 | −1 372 | −1 031 | 291 | −126 |
| Net financials | 116 | 15 651 | — | −3 | 18 185 |
| Profit before tax | −178 | 14 279 | −1 031 | 289 | 18 059 |
| Tax | −0 | — | — | — | — |
| Net profit | −178 | 14 279 | −1 031 | 289 | 18 059 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 567 | 15 457 | 13 429 | 12 933 | 29 961 |
| Equity | 1 144 | 15 422 | 13 391 | 12 680 | 29 739 |
| Long-term debt | 577 | — | — | — | — |
| Short-term debt | 0 | 34 | 38 | 253 | 222 |
| Total debt | 577 | 34 | 38 | 253 | 222 |
EBITDA margin
39.7%
This company
15.8%
Market median
+151% vs market
20202024
Equity ratio
99.3%
This company
38.2%
Market median
+160% vs market
20202024
Return on equity
60.7%
This company
18.4%
Market median
+230% vs market
20202024
Net profit margin
1877.2%
This company
8.1%
Market median
+23075% vs market
20202024
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20202024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Inorelax AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Fredrik Lundqvist | Board of Directors | 0 companies |
| Shany Poijes | Deputy Board Member | 0 companies |